Add 100mL of distilled or deionized water to the product. Allow about 5 minutes for the powder to dissolve.
S5814
Stop Reagent for TMB Substrate
chromogenic, powder
Synonyme(s) :
TMB liquid substrate system stop reagent
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
Sélectionner une taille de conditionnement
100 ML
53.30 CHF
53.30 CHF
Check Cart for Availability
Sélectionner une taille de conditionnement
Changer de vue
100 ML
53.30 CHF
About This Item
Code UNSPSC :
12352204
Nomenclature NACRES :
NA.83
53.30 CHF
Check Cart for Availability
Produits recommandés
Nom du produit
Stop Reagent for TMB Substrate, powder, ELISA, 450 nm
Forme
powder
Température de stockage
room temp
Catégories apparentées
Description générale
Stop Reagent for TMB Substrate is used to stop TMB substrate reaction for ELISA and change the absorbance from blue (620 nm) to yellow (450 nm).
Mention d'avertissement
Danger
Mentions de danger
Conseils de prudence
Classification des risques
Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Eye Dam. 1 - Skin Corr. 1 - Skin Sens. 1 - STOT SE 3
Organes cibles
Respiratory system
Code de la classe de stockage
8A - Combustible corrosive hazardous materials
Classe de danger pour l'eau (WGK)
WGK 3
Point d'éclair (°F)
260.6 °F - closed cup
Point d'éclair (°C)
127 °C - closed cup
Faites votre choix parmi les versions les plus récentes :
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Les clients ont également consulté
Romesh R Subramanian et al.
Nucleic acids research, 43(19), 9123-9132 (2015-10-09)
The in vivo potency of antisense oligonucleotides (ASO) has been significantly increased by reducing their length to 8-15 nucleotides and by the incorporation of high affinity RNA binders such as 2', 4'-bridged nucleic acids (also known as locked nucleic acid
Prevalence of interfering antibodies in dogs and cats evaluated using a species-independent assay
Bergman D, et al.
Veterinary Clinical Pathology / American Society For Veterinary Clinical Pathology, 47(2), 205-212 (2018)
Marília Santini-Oliveira et al.
Vaccines, 10(10) (2022-10-28)
We report the successful closure of Phase I clinical trials, comprising Phases Ia and Ib, of the vaccine candidate against human schistosomiasis: the Schistosoma mansoni 14 kDa fatty acid-binding protein (Sm14) + glucopyranosyl lipid A in squalene emulsion (GLA-SE). Shown
Myeloid-specific deletion of peptidylarginine deiminase 4 (PAD4) mitigates atherosclerosis.
Liu Y, et al.
Frontiers in Immunology, 9, 1680-1680 (2018)
Fresthel Monica M Climacosa et al.
Protein and peptide letters, 27(10), 962-970 (2020-04-29)
Microbe-Binding Peptides (MBPs) are currently being investigated to address the problem of antimicrobial resistance. Strategies enhancing their antimicrobial activity have been developed, including peptide dimerization. Here, we present an alternative approach based on peptide polymerization, yielding hapten-labelled polymeric MBPs that
-
With what solution to reconstitute the powder?
1 answer-
Helpful?
-
Active Filters
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique
